Research Article

Dextran-Polyacrylamide as Matrices for Creation of Anticancer Nanocomposite

Figure 4

Viability (%) of U-937 (a) and K-562 (b) cells after treatment with the nanoparticles (D-g-PAA(PE) and D-g-PAA(PE)/cisplatin) assessed by MTT test. Data are means ± SD; difference between two groups ().
(a)
(b)